Remove data-products
article thumbnail

RSV monoclonal Beyfortus was 90% effective at preventing hospitalizations in children this winter: CDC

STAT

A new monoclonal antibody product to protect against respiratory syncytial virus was 90% effective at preventing little children from being hospitalized with RSV, according to new data from the first season it was in use. These are the first real-world data showing how effective the product was in the United States.

Hospitals 361
article thumbnail

Inizio Engage: Elevating healthcare product launches through smart data

Outsourcing Pharma

A recent Deloitte report revealed that 36% of healthcare product launches fell short of achieving 80% of their sales targets within the first two years.

59
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

STAT+: FDA warns medical device makers about rise in fabricated data

STAT

An increasing number of medical device companies are submitting fabricated and unreliable data, the Food and Drug Administration noted Tuesday morning. The data comes from third-party labs hired by device firms to test the quality of their products. Triple-check your data or we’ll reject your device, the FDA warned.

350
350
article thumbnail

RSV vaccines may be linked to small increased risk of developing Guillain-Barré syndrome, data suggest

STAT

The new vaccines that protect older adults against respiratory syncytial virus, or RSV, may be linked to a small increased risk of developing Guillain-Barré syndrome, new data from the Centers for Disease Control and Prevention and the Food and Drug Administration suggest. Read the rest…

Vaccines 354
article thumbnail

STAT+: The next frontier in data privacy? Your brain

STAT

You can buy a funky-looking headband for $500 on the internet if you want your own personal EEG to track your brain data. The group analyzed the user agreements and privacy policies for 30 companies that sell commercially available products. Fewer than half of the companies surveyed encrypt their data and de-identify users.

HIPAA 265
article thumbnail

Better Data, Better Outcomes: A LexisNexis® Risk Solutions and Q1 Productions Webinar

Drug Channels

Better Data, Better Outcomes: A LexisNexis ® Risk Solutions and Q1 Productions Webinar. Your business depends on the data collected everyday across healthcare. That data not only drives the validation of the products and services your company offers today, but it also generates opportunities for new products and services.

62
article thumbnail

How Real-Time Data Helps Business Development Teams with New Product Acquisition Research

InCrowd

Learn why a pharmaceutical company considering acquiring a new product asset in a space with noticeable market movement turned to InCrowd’s global qualitative and quantitative solutions to uncover opportunities in product administration and identify an unmet market need. Get the results in our latest case study.